Skip to content

Author

D. Führer

We have 4 of 363 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Score interpretation thresholds for the European Organisation for Research and Treatment of Cancer thyroid cancer quality of life questionnaire (EORTC QLQ-THY34). An international prospective study

The European Organisation for Research and Treatment of Cancer Thyroid Cancer Quality of Life (QoL) Module (EORTC QLQ-THY34) is a valid tool to assess QoL in this patient population. The present study established estimates for score interpretation thresholds for this instrument when using it with thyroid cancer patient...

Susanne Singer, G. Sykiotis, M. Pinto et al. · 0 citations
Jun 2026

Aktuelle Therapieoptionen beim anaplastischen Schilddrüsenkarzinom im Kontext der S3-Leitlinie

Zusammenfassung Das anaplastische Schilddrüsenkarzinom (ATC) ist eine seltene, hochaggressive Tumorerkrankung, die eine rasche Diagnosestellung und interdisziplinäre Therapieplanung erfordert. Die aktuelle S3-Leitlinie empfiehlt ein multimodales Behandlungskonzept aus Chirurgie, Strahlentherapie und systemischer Therap...

Yara Maria Machlah, D. Führer, Tim Brandenburg · 0 citations
Review Aug 2026

Kontinuierliche Glukosemessung und automatisierte Insulindosierungssysteme im klinischen Alltag

A practice-oriented evaluation of the indications, clinical benefits, and safety of modern diabetes technologies and suggests that technologies should be offered according to individual needs, abilities, preferences, and life circumstances and implemented early, including at the time of diagnosis.

A. Mathew, D. Führer · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.